stockrowArmata Pharmaceuticals, Inc. (ARMP) vs Coherus Oncology, Inc. (CHRS)
- Armata Pharmaceuticals, Inc. ARMP 3.37 +12.33%
- Coherus Oncology, Inc. CHRS 0.77 +2.67%
Armata Pharmaceuticals, Inc. and Coherus Oncology, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Coherus Oncology, Inc. are of similar size ($115.7M and $111.5M). Coherus Oncology, Inc. grew revenue faster over the last twelve months: 61.0% against −19.3%. Coherus Oncology, Inc. has the higher net margin (−259.4% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 18 metrics below, Coherus Oncology, Inc. leads on 12 and Armata Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ARMP | CHRS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 68.94% | 68.51% |
| Operating margin | (734.19%) | (311.56%) | 0.00% |
| Net margin | (3,467.04%) | (259.41%) | 0.00% |
| Free cash flow margin | (465.34%) | (365.22%) | 0.00% |
| Return on equity | 127.83% | (146.27%) | (51.96%) |
| Return on assets | (225.11%) | (41.90%) | (46.06%) |
| Return on invested capital | (89.61%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack